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Summary 
Familial clustering  of autoimmune  thyroid  diseases has led to studies  of their association with 
human  major histocompatibility complex (MHC)  class  II genes.  One such gene implicated in 
Hashimoto's thyroiditis  (HT) is HLA-DR3,  but the association is weak and is contradicted by 
other  reports.  On  the  other  hand,  murine  experimental  autoimmune  thyroiditis  (EAT),  a 
model for HT, presents a clear linkage with MHC  class II. Moreover, it is inducible with thy- 
roglobulin  (Tg), the common autoantigen  in either species. Immunization of HLA-DRBI*0301 
(DR3)  transgenic  mice  with  mouse  or human  Tg resulted  in  severe  thyroiditis.  In  contrast, 
transgenic  mice  expressing  the  HLA-DRBI*1502  (DR2)  gene  were  resistant  to  EAT.  Our 
studies  show  that  HLA-DRB1  polymorphism  determines  susceptibility  to  autoimmune  thy- 
roiditis and implicate Tg as an important autoantigen. 
A 
well known model for Hashimoto's thyroiditis  (HT) is 
murine  experimental autoimmune  thyroiditis  (EAT). 
Susceptibility  to  this  T  cell-mediated  disease  is  linked  to 
H2A class  II molecules of the routine  major histocompati- 
bility complex (MHC), which can present thyroiditogenic, 
highly  conserved  T  cell  epitopes  on  thyroglobulin  (Tg) 
from both the mouse (M) and human (H) (1, 2). In contrast 
with  studies  on  EAT,  patient  studies  over the  past  15  yr 
have not revealed a clear HLA association with HT despite 
improved typing techniques,  although it is clear that ethnic 
variations  exist.  Several  studies  in  Caucasians  have  impli- 
cated  both  DRBI*0301  (DR3)  and  DRBl*11011  (DR5) 
(3-8).  However,  a  negative  association  with  DR3  (9)  or 
lack  of any DR  region  association  has  also  been  reported 
(10-12).  Recently,  certain HLA-DQ  alleles have also been 
implicated,  even  though  the  associations  are  complicated 
by  linkage  disequilibrium  with  DR  loci.  For  instance, 
while  the  DQBI*0201  (DQw2)  gene  has been  implicated 
in  HT,  its  involvement  is  questionable  owing  to  linkage 
with DR3  (6, 8,  13). Using HLA-DR  and HLA-DQ  trans- 
genic  mice,  we  can  address  the  specific  role  of each  HLA 
class  II gene in human thyroid disease. We report here that 
EAT  is  induced  in  HLA-DR3  (DRBI*0301)  transgenic 
mice immunized with either MTg or HTg, an autoantigen 
also in the  human.  In contrast,  DRB1*1502  (DR2)  trans- 
genic mice were unresponsive to MTg. Thus, DRBI  poly- 
morphism  is  a  determining  factor  in  susceptibili W  to  au- 
toimmune thyroiditis. 
Materials and Methods 
Tgs and Adjuvant.  MTg and HTg from frozen thyroids were 
fractionated  on  a  Sephadex  G-200  column  (Pharmacia Biotech 
Inc., Piscataway, NJ) and checked for purity by immunoelectro- 
phoresis as detailed previously (14).  Salmonella enteritidis LPS was 
prepared by TCA precipitation. 
Generation of HLA-DRB1  Transgenic Mice.  The generation of 
DRBI*0301  (DR3)  transgenic mice by coinjection of an HLA- 
DRoL genomic fragment and a DRB1*030113  gene fragment into 
(C57BL/6  ￿  DBA/2)F 1 ￿  C57BL/6  embryos and backcross to 
B10 mice was detailed previously (15).  In the specific pathogen- 
free facility  at Mayo Clinic,  the  DR3  transgene was first  intro- 
duced into B10.M mice by repeated backcrossing. Subsequently, 
the DR3  gene was introduced  into the class II-negative H2Ab  ~ 
strain  (16) by  mating  the  B10.M-DRBI*0301  line  with  the 
B10.Ab ~} line,  similar  to the strategy detailed recently for HLA- 
DQ  transgenic  mice  (17).  PBLs were  typed for expression and 
segregation during breeding by flow cytometry using the follow- 
ing  monoclonal  Abs:  L227,  anti-DRB1  (18);  AF6-120,  anti- 
H2A  b (19);  28-14-8S,  anti-H2D b (20);  14-4-4S,  anti-H2E  (21); 
3F-12, anti-H2A t (22). 
DRBl*1502.Ab ~ (HLA-DR2,  H2Ab  ~  transgenic  mice were 
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tive founder  mice were obtained by microinjecting a  linearized 
34  kb  DNA fragment  containing  the  entire  DRB1*1502  gene, 
isolated from the  HLA-homozygous B  cell line AKIBA (DR2, 
Dw12, DQw6) (24),  into (SWR X B10.M)F  2 embryos and iden- 
tified by PCI~ using the  primers  5'-C(CT)TAAGAGGGAGT- 
GTCATTTCTTC-3'  and  5'-TGTCAAGCTCTC(AC)(AC)- 
CAACCCC-3'  in  the  second  DRB1  exon.  The  DRB1*1502 
transgene was then introduced into class II-negative Ab  ~ mice by 
mating. To get expression of the D1LB1*1502 molecule, the mice 
were also mated with Ab~.Eot k transgenic mice. The high homol- 
ogy  between  Dl<c~  and  E~  chains  enables  the  pairing  of  the 
DRB1*1502  chain  with Eot  (25).  DP,2  (Dw12)  expression was 
detemfined with the DR.Bl-specific L227 mAb by flow cytometry. 
Induction and Assay of EAT.  Mice  were  housed  in  a  patho- 
gen-free facility on acidified, chlorinated water upon  arrival and 
used at 8-16 wk of age. They were immunized intravenously on 
days 0 and 7 with 40 p.g of MTg or 100 b~g of HTg, followed by 
20  p,g of LPS 3  h  later.  On day 28,  sera and thyroids were col- 
lected; there were no discernible gender influences in results. As 
previously described, anti-MTg and anti-HTg titers were deter- 
mined  either by passive hemagglutination  with MTg-  or HTg- 
coated human group O  RBCs (14)  or by ELISA (2).  In brief, re- 
agents  for  ELISA were  96-well  plates  (hnmulon  II;  Dynatech 
Laboratories,  Inc.,  Chantilly, VA) coated with  1  p,g per well of 
MTg  or  HTg,  PBS/Tween  20  for  washing,  PBS/1%  BSA  for 
blocking,  and  alkaline  phosphatase-conjugated  goat anti-mouse 
Ig  H  and  L  chains  (Southern  Biotechnology Association,  Inc., 
Birnfingham, ALl as the second Ab.  Serum dilutions were tested 
at 1:100,  1:800, and 1:3,200 with standard immune sera and nor- 
real serum as controls. 
Thyroid inflammation was determined histologically from 30- 
60 sections  (7-10  step levels) containing both thyroid lobes, and 
the percentage of mononuclear cell infiltration and destruction in 
individual mice was recorded (26).  Thyroids with > 10% involve- 
ment  showed  definite follicular destruction  accompanying  focal 
areas of infiltration. 
In Vitro Prolferation.  Cellular proliferation was carried out as 
detailed previously (26,  27).  In brief, on day 28 after immuniza- 
tion with MTg or HTg, spleen cells (SCs)  were cultured for 4 or 
5 d in flat-bottomed, 96-well plates (6  ￿  105 cells per well) with 
40  btg/ml of either Tg.  For blocking of Ag presentation,  HLA- 
specific and  control mAbs were added  to cells at the concentra- 
tions indicated in the legend, with or without Tg.  Culture me- 
dimn  consisted  of P,  PMI  1640  medium  with  25  mM  Hepes 
.a.ntlgen  DR3 
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Figure  1.  Comparison  of T cell proliferative response and Ab titers to 
MTg  and  HTg after  inmmnization  of I)R3  transgenic,  EAT-resistant 
B10.M  mice with either  Tg. Note that  only the T  cell proliferative re- 
sponse to self-Ag MTg is correlated with acquired susceptibility to EAT 
induction as seen in Table 1, since it is not masked by response to foreign 
epitopes  on HTg.  (A) On day of thyroid  removal,  SCs from  MTg- or 
HTg-inmmnized DR3 + and DR3- B10.M mice were cultured  (6 X 1(1  ~ 
cells per well) for 5 d with (black bar) or without (open bar) 4(1 p.g/ml MTg 
or HTg, and [3H]thymidine uptake was measured. (B) Anti-MTg or anti- 
HTg titers were assayed by passive hemagglutination  of MTg- or HTg- 
coupled R.BCs and expressed as reciprocal log  2 titers. Sigmificantly  higher 
anti-MTg titers were detected in DR3 + BI0.M mice. 
buffer,  supplemented  with 2  mM glutamine,  100  U/ml penicil- 
lin,  100  Ixg/ml streptomycin  (all from  GIBCO  BRL,  Gaithers- 
burg, MD), 50 p.M 2-ME (Sigma Chemical Co., St. Louis, MO), 
and  1%  normal  mouse  serum.  After  pulsing  with  1.2  b~Ci of 
[3H]thymidine (ICN Biomedicals, Inc., Costa Mesa, CA) for the fi- 
nd 18 h, the ceils were harvested on glass fiber filters. [3H]Thymi- 
dine uptake in triplicate cultures was determined in an LKB-Wal- 
lac liquid scintillation counter (LKB-Wallac, Turku,  Finland). 
Results  and  Discussion 
BIO.M-DR3 +  Transgenic  Mice  Are  Susceptible  to  EAT. 
Initial  DR3  gene  transfer  experiments  were  conducted  in 
EAT-resistant B10.M  mice after mating with DRBI*0301 
transgenic mice and backcrossing to B10.M mice. Immuni- 
zation with either MTg  or HTg  resulted in thyroid inflam- 
mation in the B10.M-DRBI*0301  mice (Table  1). Marked 
infiltration  of mononuclear  cells and  destruction  involving 
up  to  40%  of both  thyroid  lobes  were  present  in  80%  of 
MTg-immunized  DR3 + mice, compared with none in the 
Table  1.  Acquired  Susceptibility  to EAT Induction  qfter Insertion of HLA-DRBI*0302  (DR3) Transgene into Resistant BIO.M Mice 
Thyroiditis* 
Number of mice with percent thyroid involvement  Incidence 
DR3 
Antigen  expression  0  >0-10  > 10-20  >20-40  Positive/total  % 
MTg  +  1  --  --  4  4/5  8(/ 
-  4  --  --  --  0/4  0 
HTg  +  --  --  2  3  5/5  100 
-  2  2  --  --  2/4  50 
* Mice were immunized with 40 beg of MTg or 100 p.g of HTg and 20 btg of LPS intravenously  3 h later on days 0 and 7 and were killed on day 28. 
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Thyroiditis* 
Number of mice with percent thyroid involvement  Incidence 
Transgene  Tg antibody 
Antigen  expression  (OD 1:800)  0  >0-10  >10-20  >20-40  >40-80  Positive/Total  % 
MTg  Nones  <0.2  3  ....  0/3  0 
DR3+E +  0.58  -+ 0.07  --  --  --  3  2  5/5  100 
DR3-E +  <0.2  2  ....  0/2  0 
DR3+E -  0.73  -4- 0.05  --  --  1  --  5  6/6  100 
DR3-E  <0.2  5  ....  0/5  0 
HTg  DR3+E -  ND  1  --  2  2  1  5/6  83 
DR3-E  ND  6  ....  0/6  0 
*See Table 1 for experimental protocol. 
*Class lI-negative H2Ab" control mice. 
DR3-  sibs, which remained resistant. In HTg-immunized 
mice, all the DR3 + mice displayed similarly typical inflam- 
mation  of  >10-40%.  The  DR3-  mice  were  essentially 
negative; a focal perivascular infiltration in two mice could 
be  due  to  a  low  response  mediated by  endogenous  H2A 
molecules.  In  addition  to  conserved  epitopes  shared  be- 
tween MTg and HTg,  HTg  contains foreign epitopes that 
are known to stimulate T  and B  cells of both EAT-suscep- 
tible and EAT-resistant mice (26, 27). Thus, in Fig. 1, both 
DR3 +  and DR3-  mice responded strongly and  compara- 
bly to HTg in both in vitro proliferative response and anti- 
HTg production, in contrast with the differential response 
to MTg.  These data show that the DR3  transgene renders 
a  resistant  strain  susceptible  to  EAT  induction  by  either 
MTg or HTg. 
DR3.Ab  ~ Mice Are Susceptible to EAT.  To  define the  ex- 
tent  of DR3  influence  in  EAT  susceptibility,  the  DR3 
transgene  was  introduced  into  H2Ab  ~ mice,  the  class  II- 
negative strain, by mating with B10.M-DRBI*0301  mice. 
The  Ec~  k  transgene  (Ab~  k)  was  introduced  into  some 
mice to compete with the pairing between the DRot mole- 
cule and the endogenous El3  b molecule and to determine a 
role for Eot and E~ chains. These mice do not express any 
H2A  molecules.  Initial  experiments  on  EAT  induction 
with  MTg  not  only  showed  that  EAT  was  induced  in 
DRBI*0301.Ab ~ mice, but also that expression of the EB  b 
molecules  played  no  role.  Table  2  presents  typical  data 
from such MTg-immunized  groups.  Severe thyroiditis in- 
volving up to 80% of the gland was observed in all the ani- 
mals from both DR3 + groups regardless of E[3  b expression 
(Fig.  2  A).  The  presence  of the  EJ3 b molecule  in  D1K3- 
mice  did not  result  in  thyroiditis (see  also  Table  3).  The 
DR3  transgene in the E-Ab  ~ mice also responded to HTg 
immunization with 83% incidence of thyroid inflammation 
Figure 2.  Thyroid inflammation with typical mononuclear cell infiltrates involving "40% of the gland in MTg-immunized  (A) or HTg-immunized 
(B) HLA-DR3 transgenic, class lI-negative H2Ab" mice (originally 100X). 
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in H2Ab  ~ Mice 
Thyroiditis* 
Number of mice with percent thyroid involvement  Incidence 
Transgene  MTg antibody 
expression  (OD  1:800)  0  >0-10  >10-20  >20-40  >40-80  Positive/Total  % 
DR3+E +  0.74 _+ 0.16  1  --  4  4  1  9/10  9{) 
DR3-E +  <0.2  7  ....  0/7  0 
DR2+E +  <0.2  7  ....  0/7  0 
DR2-E +  <0.2  13  ....  0/13  {} 
*See Table 1 for experimental protocol. 
averaging 30%  of the gland (Fig. 2  /3).  In both MTg- and 
HTg-immunized  mice,  high  anti-MTg  Ab  titers  (detect- 
able at  1:800  dilution) were observed only in DR3 + mice 
(anti-HTg titers tested separately). 
DR2.Ab ~ Mice Are Resistant to EAT.  The role of HLA- 
DRB1  polymorphism  in  susceptibility to  thyroiditis was 
tested  with  HLA-DR2  transgenic  mice.  The  DRB1- 
"1502.Ab  ~  (DR2Dw12)  mice  were  generated  by  mating 
positive founder  mice  with  class  II-negative Ab  {J  mice  as 
well as  EoL  k  transgenic mice. After MTg immunization, all 
DR2 +  mice displayed resistance to EAT,  in  contrast with 
DR3 + mice, which exhibited marked to severe thyroid in- 
flammation (Table 3). A  repeat experiment with DR2+E + 
(seven  mice)  and  DR2-E +  (six mice)  groups  immunized 
with  MTg  also  revealed  no  significant  thyroid  involve- 
ment,  compared with all nine DR3 + mice with thyroiditis 
(data not shown). In both experiments, the anti-MTg titers 
in DR2 + mice were undetectable at  1:800 dilution. Upon 
DR3  mAb 
§  -I 
+  DRI~ ~" 
+  DR(x 3 
+  CD4 
A  mAb  B 
7 
3 
Sp 
D  b 
mean CPM x 10-~ :1: SE 
10  16  20  26  30  35  40 
Figure 3.  MTg presentation to SC from MTg-immunized DR3 + Ab  ~' 
mice was specifically  blocked by mAb to DR[3 (L227; supernatant l:10) 
(18), as illustrated in A and B. (A) SCs from DR3+E + mice, blocking by 
1nAb to DRc~ (L243; 50 la,  g/ml) and to mouse CD4 (YTS 177.9; 25 l~g/ 
ml). (B) SCs from DR3§  - mice, no blocking by mAb to D  6 (28-14-8S; 
supernatant 1:40) or El3  t' (Y17; supematant  1:10) (21), [3H]Thymidine 
uptake was measured after 4 d in culture in the presence of mAb only 
(background cpm, open bar) or 40 btg/nfl MTg plus mAb (black bat). Con- 
trol proliferative assay to MTg in DR3 + and DR3  Ab  {' mice was per- 
formed with (black bar) or without (open bar) MTg. 
retesting,  only  two  mice  had  detectable  OD  values  be- 
tween  0.2  and  0.5  at  1:100.  Furthermore,  as  in  MTg- 
immunized DR3-E  mice, DR2-E-  mice were uniformly 
unresponsive (data not shown). 
H2E~ and H2Ea Genes Do Not Play a Role.  Because  DRo~ 
is highly homologous  to  Eot  (25),  in  the  DR3  transgenic 
mice, four combinations of class II molecules could be gen- 
erated:  DR(xDR[3,  EclE[3,  DRcIE[3,  and  EotDR~.  Some 
mice  could express  all four forms,  while  others,  only the 
cis-pairing.  In  mice  lacking  the  Fix  gene,  only  the 
DRciDR[3  and  DRotE~  combinations  are  possible,  with 
some mice expressing only the cis-pairing.  Susceptibility to 
EAT  clearly required  the  expression  of the  DRBI*0301 
gene. The resistance of all other mice negated a role for the 
H2E[3 molecule. This is further confirmed by the resistance 
ofDR2+E + transgenic mice to induction with MTg. 
Lymphocyte Proliferation to Tg is CD4 + T  Cell-mediated  and 
DR3-restricted.  The function of DR3 molecules in vivo as 
classic Ag presenters during EAT induction was verified by 
in vitro blocking studies  with  mAbs to  DRcr  and  I)RB1 
and appropriate control mAbs. Fig. 3 shows that the prolif- 
erative responses to MTg of primed SCs were blocked by 
both mAbs, reducing the response to near background lev- 
els of cells plus only mAb in the absence of MTg. In Fig. 3 A, 
a  rat  mAb  to  mouse  CD4  served  as  positive  control  for 
blocking MTg proliferation (28).  The abrogation of T  cell 
proliferative response by anti-DR~ in DR3+E + mice con- 
firms that pairing of DRotDR~  is preferred. In Fig. 3 B, Ag 
presentation was  not  blocked by  anti-D  b,  a  control  anti- 
class  I  mAb.  More  importantly,  proliferation was  not  af- 
fected  by  anti-E[~  b,  indicating  that  DRotE~  pairing  was 
minimal and not involved in MTg-priming.  Similarly, the 
proliferative response  to  HTg  of SCs  from  HTg-mmm- 
nized D1K3 +  mice was inhibited by mAbs to  either DRot 
or DRB1  (data not shown). 
In  conclusion,  our  findings  demonstrate  an  important 
role for the  HLA-DR3  gene  in susceptibility to  HT.  The 
conflicting reports on HT and DR3  association mentioned 
earlier are complicated by low relative risk  (2.2-3.5), link- 
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HLA-B8 (3, 5, 8), unknown modifying background genes, 
and  different  typing techniques.  On  the  other  hand,  our 
transgenic  mice  express  uniform  background  genes  with 
specific HLA class II genes. Our evidence associating DR3 
and dissociating DR2 from EAT underscores the usefulness 
of this  DRB1  transgenic  model  to  pinpoint the  involve- 
ment of particular HLA genes in HT. The DR3 association 
in autoimmune thyroiditis induced by either HTg or MTg 
also  demonstrates  the  importance  of Tg  as  a  thyroid au- 
toantigen, possibly involved in human  pathogenesis rather 
than just as a diagnostic tool to be replaced by thyroperoxi- 
dase,  the microsomal Ag.  Our  data suggest that  the long- 
time usage  of Tg as a  model antigen  in murine  EAT  has 
real relevance. The use of a humanized model should iden- 
tify potential  Tg  epitopes  involved in  human  disease.  As 
more  HLA transgenic mice become  available, the impor- 
tance of other class II genes, such as DQ, and other thyroid 
Ags may be learned. 
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